02/14/2024
1:21 PM | Aridis Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:02 PM | Aridis Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
01/16/2024
5:05 AM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
8:40 AM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
8:43 AM | Aridis Pharmaceuticals (Filer)
| Form DEFA14A | |
11/06/2023
3:06 PM | Aridis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
4:00 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/03/2023
5:15 AM | Aridis Pharmaceuticals (Filer)
| Form DEFA14A | |
09/13/2023
8:47 PM | Aridis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/08/2023
9:13 AM | Aridis Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/07/2023
3:15 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
11:15 PM | Aridis Pharmaceuticals (Filer)
| Form EFFECT | |
07/21/2023
5:49 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
07/20/2023
4:18 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
7:00 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
2:01 PM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
07/17/2023
6:36 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
06/27/2023
2:15 PM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
06/15/2023
4:16 PM | Aridis Pharmaceuticals (Issuer)
Patzer Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:09 PM | Aridis Pharmaceuticals (Issuer)
KURLAND FRED (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:11 PM | Aridis Pharmaceuticals (Issuer)
Jafri Hasan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:12 PM | Aridis Pharmaceuticals (Issuer)
Windham-Bannister Susan Richards (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:13 PM | Aridis Pharmaceuticals (Issuer)
Truong Vu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:14 PM | Aridis Pharmaceuticals (Issuer)
HAMILTON JOHN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:13 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
05/22/2023
4:31 PM | Aridis Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/22/2023
4:22 PM | Aridis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/16/2023
1:26 PM | Aridis Pharmaceuticals (Filer)
| Form NT 10-Q | |
